Friday, April 26, 2024
MARKET UPDATE
Advertisement Topt

TheCable

Advertisement lead

NPHCDA: Over 1.2m vaccinated against COVID-19 in two months

NPHCDA: Over 1.2m vaccinated against COVID-19 in two months
May 06
11:03 2021

Nigeria has vaccinated 1,266,742 persons against COVID-19, two months after nationwide rollout commenced on March 5. 

Vaccination has taken place in the 36 states of the federation and the federal capital territory (FCT).

According to a May 5 update by the National Primary Health Care Development Agency (NPHCDA), Lagos, the epicenter of the pandemic in the country, tops the list with 236,663 persons vaccinated, followed by Kaduna with 65,899 and Kano with 63,072.

Bayelsa is the least in terms of the number of vaccinated persons, with 11,078 persons vaccinated, followed by Ebonyi with 11,742 persons and Taraba with 11,999 persons.

Advertisement

The development means that the country managed to administer an average of 20,766 doses daily.

Nigeria received close to 4.5 million doses of the Oxford/AstraZeneca vaccine — 3.94 million delivered via the United Nations-led COVAX facility, while others are donations from India and private organisations.

 

Advertisement

On April 26, the federal government announced that it was expecting to receive 29.8 million doses of the Johnson & Johnson vaccine through the African Union (AU).

The government also said it will take delivery of more vaccines through the UN-led COVAX facility before the end of June.

The National Agency for Food and Drug Administration and Control (NAFDAC) on April 30 approved the emergency use of Pfizer COVID-19 vaccine in Nigeria.

So far, Nigeria has recorded 165,273 COVID-19 infections while 7,789 patients are currently receiving treatment for the virus.

Advertisement

Click on the link below to join TheCable Channel on WhatsApp for your Breaking News, Business Analysis, Politics, Fact Check, Sports and Entertainment News!

Tags

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

error: Content is protected from copying.